Niagen Bioscience, Inc. (NAGE) KPIs and segments
Close on Nov 17, 2026Market cap $161.42MP/E 17.0Yield –
KPIs & segments
Operating metrics and segments that drive Niagen Bioscience's business
Niagen Bioscience's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Consumer Products segment($M) | 24.2 | 22.4 | 27.5 | 26.0 | 22.7 | 21.5 | 22.7 | 18.1 | 18.6 | 17.4 | 17.6 | 17.4 | |
Ingredients segment($M) | 5.39 | 8.56 | 5.69 | 7.20 | 7.62 | 8.17 | 5.75 | 6.67 | 3.30 | 4.09 | 2.89 | 1.42 | |
Corporate and other($M) | 0.24 | 0.07 | |||||||||||
Analytical Reference Standards and Services segment($M) | 0 | 0.42 | 0.69 | 0.77 | 0.80 | 0.81 | 0.72 | 0.78 | 0.79 | 0.71 | 0.71 | 0.67 | |
Pharmaceuticals segment($M) | 0 | 0 | 0 | 0 | |||||||||
Consumer Products segment($M) | 5.57 | 4.64 | 9.75 | 7.42 | 6.28 | 5.51 | 6.53 | 3.79 | 3.95 | 2.91 | 3.83 | 4.30 | |
Ingredients segment($M) | 2.60 | 4.54 | 3.94 | 3.80 | 4.46 | 4.75 | 3.45 | 4.10 | 1.51 | 1.84 | 1.58 | 0.59 | |
Analytical Reference Standards and Services segment($M) | 0 | 0.07 | 0.11 | 0.14 | 0.09 | 0.06 | -0.05 | 0.01 | -0.05 | -0.12 | -0.15 | -0.19 | |
Pharmaceuticals segment($M) | -0.48 | -0.47 | -0.37 | -0.37 | |||||||||
Consumer Products segment($M) | 16.3 | 14.8 | 18.1 | 17.5 | 15.2 | 14.1 | 14.6 | 11.6 | 11.9 | 11.2 | 11.2 | 11.4 | |
Ingredients segment($M) | 3.01 | 5.01 | 3.42 | 4.25 | 4.81 | 5.07 | 3.50 | 4.50 | 1.76 | 2.25 | 1.76 | 0.69 | |
Analytical Reference Standards and Services segment($M) | 0 | 0.12 | 0.19 | 0.22 | 0.17 | 0.17 | 0.07 | 0.13 | 0.08 | 0.01 | -0.06 | -0.09 | |
Pharmaceuticals segment($M) | 0 | 0 | 0 | 0 | |||||||||
28 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-04.
See a number that looks wrong?